NEW YORK – 10x Genomics reported after the close of the market on Thursday a 33 percent year-over-year increase in preliminary first quarter revenues.
For the quarter ended March 31, the company reported preliminary revenues between $71 million and $72 million. The firm saw "a significant reduction in customer activity other than research related to the virus" during the quarter as many academic and government labs temporarily closed due to the pandemic.